Virtus ETF Advisers LLC Myovant Sciences Ltd. Transaction History

Virtus ETF Advisers LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$24.03 - $27.02 $274,879 - $309,081	-11,439 Reduced 50.41%	11,251 $303,000
Q3 2022 Nov 14, 2022	BUY	$11.6 - $20.44 $3,874 - $6,826	334 Added 1.49%	22,690 $408,000
Q2 2022 Aug 12, 2022	BUY	$7.78 - $14.69 $91,033 - $171,887	11,701 Added 109.82%	22,356 $278,000
Q1 2022 May 16, 2022	SELL	$11.38 - $16.4 $7,214 - $10,397	-634 Reduced 5.62%	10,655 $142,000
Q4 2021 Feb 14, 2022	BUY	$14.31 - $23.87 $21,951 - $36,616	1,534 Added 15.73%	11,289 $176,000
Q3 2021 Nov 15, 2021	SELL	$18.94 - $26.99 $9,754 - $13,899	-515 Reduced 5.01%	9,755 $219,000
Q2 2021 Aug 10, 2021	SELL	$17.07 - $24.56 $37,332 - $53,712	-2,187 Reduced 17.56%	10,270 $234,000
Q1 2021 May 17, 2021	BUY	$20.46 - $25.18 $4,521 - $5,564	221 Added 1.81%	12,457 $256,000
Q4 2020 Feb 12, 2021	SELL	$13.8 - $27.62 $84,014 - $168,150	-6,088 Reduced 33.22%	12,236 $338,000
Q3 2020 Nov 13, 2020	SELL	$14.05 - $22.6 $35,026 - $56,341	-2,493 Reduced 11.98%	18,324 $257,000
Q2 2020 Aug 05, 2020	SELL	$7.34 - $20.84 $22,592 - $64,145	-3,078 Reduced 12.88%	20,817 $429,000
Q1 2020 May 14, 2020	SELL	$6.55 - $14.76 $22,754 - $51,276	-3,474 Reduced 12.69%	23,895 $180,000
Q4 2019 Feb 13, 2020	SELL	$4.2 - $19.21 $7,606 - $34,789	-1,811 Reduced 6.21%	27,369 $425,000
Q3 2019 Nov 12, 2019	SELL	$5.19 - $9.46 $8,402 - $15,315	-1,619 Reduced 5.26%	29,180 $152,000
Q2 2019 Aug 13, 2019	BUY	$8.69 - $25.0 $267,643 - $769,975	30,799 New	30,799 $279,000

61.3K

Ticker MYOV
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 96,802,800
Description
Myovant Sciences Ltd., a biopharmaceutical company, develops redefine care for women and for men. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.